TORONTO, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and...
Research Use Only (RUO) assay now globally available for BD MAX™ System
FRANKLIN LAKES, N.J., Sept. 26, 2022 /PRNewswire/ -- BD (Becton, Dickinson and...
The present article provides additional details regarding specific aspects related to the policy for monkeypox tests, including the ones related to validation, serology tests,...
The new article describes in detail the approach to be applied concerning comparable devices including substantially equivalent devices.
Table of Contents
...
The new article describes the particular way the least burdensome provisions should be applied to facilitate and streamline the regulatory processes associated with placing...
The new article provides an overview of the medical device classification rules adopted in the European Union and highlights the key points associated thereto.
...
The new article describes in detail the means for reducing the burden of traditional clinical studies, and also the use of benefit-risk assessments.
...
Medical device company Moximed has reported data from the pivotal Calypso Study of its MISHA Knee System.
An implanted shock absorber (ISA), the MISHA Knee...
English
Arabic
Bengali
Chinese (Simplified)
Danish
Dutch
Estonian
Finnish
French
German
Greek
Hebrew
Hindi
Hungarian
Indonesian
Italian
Japanese
Korean
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Spanish
Swedish
Thai
Turkish
Ukrainian
Urdu
Vietnamese